Tissue Engineering Global Market Report 2025

Tissue engineering is a specialized field within biomedical engineering that combines biological and engineering methodologies. It aims to generate three-dimensional tissue and cellular products both in vivo (within a living organism) and in vitro (outside a living organism) by modifying cell growth conditions and utilizing appropriate cell isolates from donor tissues alongside biocompatible scaffold materials. The primary objective is to restore, repair, maintain, or enhance tissue function by replacing or regenerating damaged tissues, thereby improving human body functions.

Key categories within tissue engineering encompass synthetic scaffold materials, biologically derived scaffold materials, and other methodologies. Synthetic scaffold materials are synthetic polymers composed of fibrous proteins that simulate an extracellular matrix, promoting favorable cellular responses and behaviors in tissue engineering applications. These materials find diverse applications across orthopedics and musculoskeletal treatments, neurology, cardiovascular procedures, skin and integumentary therapies, dental applications, among others. Various end-users including hospitals, clinics, and ambulatory facilities utilize these materials for their respective medical applications.

The tissue engineering market research report is one of a series of new reports from The Business Research Company that provides tissue engineering market statistics, including the tissue engineering industry global market size, regional shares, competitors with a tissue engineering market share, detailed tissue engineering market segments, market trends and opportunities, and any further data you may need to thrive in the tissue engineering industry. This tissue engineering market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tissue engineering market size has grown rapidly in recent years. It will grow from $15.21 billion in 2024 to $17.48 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to advancements in biomaterials, growing aging population, increasing incidence of chronic diseases, regulatory support for regenerative medicine, rising patient demand for organ transplants.

The tissue engineering market size is expected to see rapid growth in the next few years. It will grow to $29.92 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to precision medicine approaches, increasing focus on immunomodulation, expanding applications in orthopedics, increased funding and investment, rising prevalence of chronic diseases. Major trends in the forecast period include integration of nanotechnology, 3d cell culture techniques, development of organ-on-a-chip technology, artificial intelligence integration, innovative cell sources.

The rising prevalence of chronic diseases and trauma emergencies is anticipated to drive the growth of the tissue engineering market in the future. Chronic diseases are defined as clinical conditions lasting three months or longer that can typically be managed but not cured, while trauma emergencies refer to physical injuries requiring immediate medical attention due to their sudden onset and severity, such as traumatic brain injuries. Healthcare professionals widely adopt tissue engineering for its numerous benefits in treating chronic disorders and trauma, helping to prevent end-stage treatment failures, including autologous or allograft transplantation, xenotransplantation, and artificial substitutes. For example, a 2023 report by the World Health Organization (WHO), a U.S.-based agency focused on promoting global health and coordinating responses to health emergencies, noted that approximately 2.4 billion people worldwide live with chronic diseases, with significant increases in conditions like diabetes and cardiovascular diseases. This growing prevalence underscores the urgent need for advanced medical treatments, including tissue engineering solutions. Furthermore, the Centers for Disease Control and Prevention (CDC) reported in 2023 that traumatic brain injuries (TBIs) remain a critical issue in the United States, with around 223,000 hospitalizations and 60,000 deaths annually, highlighting the necessity for effective interventions. Consequently, the increasing incidence of chronic illnesses and trauma emergencies is expected to significantly drive growth in the tissue engineering market.

The rising prevalence of cardiovascular disorders is projected to propel the growth of the tissue engineering market in the future. Cardiovascular disorders, or cardiovascular diseases (CVD), represent a class of medical conditions affecting the heart and blood vessels. Tissue engineering provides promising solutions for repairing and regenerating damaged cardiac and vascular tissues. For instance, in September 2024, data published by the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with about 4 million males and 3.6 million females living with these conditions. These diseases account for roughly 27% of all deaths in the UK, translating to over 170,000 fatalities annually, or about 480 deaths each day, equating to one death every three minutes. Therefore, the increasing prevalence of cardiovascular disorders is driving the growth of the tissue engineering market.

Technological advancements are a key trend gaining traction in the tissue engineering market. Major companies in this sector are concentrating on research and development to innovate products that offer improved solutions and reinforce their market positions. For instance, in August 2024, CytoNest Inc., a U.S.-based company specializing in scalable 3D cell culture platforms for adherent cell manufacturing, launched its first commercial product: a fiber scaffold designed to optimize cell manufacturing and tissue engineering. This product, known as the CytoSurge 3D fiber scaffold, has applications in cell research, biopharmaceuticals, cell therapeutics, and the development of cultured meat and seafood.

Key companies are strategically forming partnerships and collaborations with start-ups and mid-sized firms in the tissue engineering market to enhance their product and service offerings. These strategic alliances enable companies to expand their existing product portfolios and geographical presence. For example, in June 2023, Regen Lab, a Swiss-based commercial-stage medical technology company focused on the research, development, registration, manufacturing, and commercialization of proprietary tissue engineering products, entered into a collaboration agreement with Long Island University (LIU) and the Dassault Systemes Group (3DS). According to the terms of this agreement, LIU and RegenLab USA will pool resources to establish an industrial innovation accelerator, a new center of excellence dedicated to regenerative medicine and tissue engineering. Long Island University is a U.S.-based educational institution, while Dassault Systemes Group is a France-based software corporation.

In October 2022, Geistlich Pharma, a US-based company specializing in bone, cartilage, and tissue regeneration, completed the acquisition of Lynch Biologics, LLC. The financial specifics of this acquisition were not disclosed. This strategic move serves to bolster Geistlich's existing regenerative product portfolio and augments its growth prospects within the field. Lynch Biologics, the acquired company, is also based in the US and is known for its focus on regenerative medicine and tissue engineering. They specialize in supplying advanced biotechnology products aimed at fostering healing and tissue regeneration.

Major companies operating in the tissue engineering market include Medtronic plc, Zimmer Biomet, Organogenesis Holdings Inc., Integra LifeSciences, Stryker Corporation, DePuy Synthes Companies, B. Braun Melsungen AG, RTI Surgical Inc., AbbVie Inc., Becton Dickinson and Company, Baxter International Inc., BioTime Inc., Vericel Corporation, Smith and Nephew, Athersys Inc., Tissue Regenix Group plc, Xeltis AG, Prellis Biologics, Bit Bio, Be Biopharma Inc., TELA Bio Inc., Orthocell Limited

North America was the largest region in the tissue engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue engineering market during the forecast period. The regions covered in the tissue engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tissue engineering market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue engineering market consists of sales of reparative cells, bioreactive molecules, such as cytokines, growth factors, biomaterials, and bioreactors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Engineering Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue engineering market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue engineering ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tissue engineering market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Synthetic Scaffold Material; Biologically Derived Scaffold Material; Other Types
• 2) By Application: Orthopedics And Musculoskeletal; Neurology; Cardiovascular; Skin And Integumentary; Dental; Other Applications
• 3) By End-User: Hospitals And Clinics; Ambulatory Facilities
• Subsegments:
• 1) By Synthetic Scaffold Material: Polymeric Scaffolds; Ceramic Scaffolds; Composite Scaffolds
• 2) By Biologically Derived Scaffold Material: Natural Polymers; Decellularized Tissues; Hydrogels
• 3) By Other Types: Self-Healing Scaffolds; Smart Scaffolds
• Companies Mentioned: Medtronic plc; Zimmer Biomet; Organogenesis Holdings Inc.; Integra LifeSciences; Stryker Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.